Focus: Spectrum Dynamics is an advanced imaging biotech company specializing in SPECT/CT imaging technology, positioned as a public-stage player with 201-500 employees headquartered in Sarasota, Florida.
Profile data last refreshed 9h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Spectrum Dynamics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Spectrum Dynamics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Spectrum Dynamics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Radioimmunotherapy asset with CD20-targeting MOA; approaching loss of exclusivity and represents key patent cliff risk.
NDA-approved cytotoxic chemotherapy; approaching LOE and represents legacy oncology asset with declining relevance.
ANDA generic fluorouracil; post-LOE product with commodity pricing pressure and minimal strategic value.
2 discontinued, 0 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Evaluation of 9-Minute Dual-Energy Peak Time-Reduced 360° CZT Total-Body [(177)Lu]Lu-PSMA SPECT/CT Imaging with Comparisons to [(68)Ga]Ga-PSMA PET.
A deep-learning noise reduction algorithm outperforms the spatial filters previously required for bone SPECT on a high-speed whole-body 360° CZT-camera.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo